Resmed (RSMDF) EBT Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RSMDF) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 423.00 |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 773.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 773.00 |
| Mar 31, 2026 | 918.00 |
| Dec 31, 2025 | 840.00 |
| Sep 30, 2025 | 590.00 |
| Jun 30, 2025 | 795.00 |
| Mar 31, 2025 | 616.00 |
| Dec 31, 2024 | 611.00 |
| Sep 30, 2024 | 269.00 |
| Jun 30, 2024 | 194.00 |
| Mar 31, 2024 | 301.00 |
| Dec 31, 2023 | -401.00 |
| Sep 30, 2023 | -401.00 |
| Jun 30, 2023 | -286.00 |
| Mar 31, 2023 | 100.00 |
| Dec 31, 2022 | 219.00 |
| Sep 30, 2022 | 544.00 |
| Jun 30, 2022 | 755.00 |
| Mar 31, 2022 | 535.00 |
| Dec 31, 2021 | 405.00 |
| Sep 30, 2021 | 502.00 |